Literature DB >> 25189869

Influence of body fatness distribution and total lean mass on aortic stiffness in nonobese individuals.

Peter Wohlfahrt, Virend K Somers1, Ondrej Sochor2, Iftikhar Kullo1, Nathalie Jean1, Francisco Lopez-Jimenez3.   

Abstract

BACKGROUND: Subjects with normal body mass index but high body fat percentage have higher cardiovascular risk than subjects with normal weight and low fat mass. However, the association of fat distribution and lean mass with carotid-femoral pulse wave velocity (cfPWV) among nonobese apparently healthy individuals has never been assessed.
METHODS: In 136 nonobese volunteers (mean age = 45±9 years; 57% women) without manifest cardiovascular disease, cfPWV was measured by applanation tonometry. Fat and lean mass were measured by dual-energy x-ray absorptiometry.
RESULTS: In univariate analysis, total fat (r = 0.17; P < 0.01), trunk fat (r = 0.27; P < 0.01), and trunk/total fat ratio (r = 0.32; P < 0.01) were correlated with cfPWV. After adjustment for age and mean arterial pressure, only central fat distribution (trunk/total fat ratio) was significantly associated with cfPWV. In the fully adjustment model, there was a significant interaction between fat distribution and lean mass. When the study sample was grouped by fat distribution and total lean mass medians, subjects with central fat distribution and low lean mass (group 4) had higher log-transformed cfPWV than the noncentral fat/low lean mass group (group 2) (0.89, 95% confidence interval (CI) = 0.86-0.92 vs. 0.85, 95% CI = 0.83-0.87; P < 0.01) or the noncentral fat/high lean mass group (group 1) (0.89, 95% CI = 0.86-0.92 vs. 0.84, 95% CI = 0.81-0.87; P < 0.01) after adjustments. Aortic stiffness increased from group 1 to group 4 (P for linear trend < 0.001).
CONCLUSIONS: Among normal weight individuals without manifest cardiovascular disease, the combination of central fat distribution and low lean mass is associated with higher cfPWV. These factors are more closely related to cfPWV than total fat mass. © American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  DEXA; adiponectin; arterial stiffness; blood pressure; central obesity; hypertension; lean mass; normal weight obesity; pulse wave velocity.

Mesh:

Year:  2014        PMID: 25189869     DOI: 10.1093/ajh/hpu153

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  5 in total

1.  Moderating Effect of the Lean Tissue Index on the Relationship between the Trabecular Bone Score and Augmentation Index in Dialysis Naïve Patients with Stage 5 Chronic Kidney Disease.

Authors:  Byoung-Geun Han; Daewoo Pak; Jun Young Lee; Jae-Seok Kim; Jae-Won Yang; Ki-Youn Kwon
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964

2.  Relations of mitochondrial genetic variants to measures of vascular function.

Authors:  Jessica L Fetterman; Chunyu Liu; Gary F Mitchell; Ramachandran S Vasan; Emelia J Benjamin; Joseph A Vita; Naomi M Hamburg; Daniel Levy
Journal:  Mitochondrion       Date:  2017-10-07       Impact factor: 4.160

3.  Nutritional status evaluation in patients affected by bethlem myopathy and ullrich congenital muscular dystrophy.

Authors:  Silvia Toni; Riccardo Morandi; Marcello Busacchi; Lucia Tardini; Luciano Merlini; Nino Carlo Battistini; Massimo Pellegrini
Journal:  Front Aging Neurosci       Date:  2014-11-17       Impact factor: 5.750

4.  Low skeletal muscle mass is associated with arterial stiffness in community-dwelling Chinese aged 45 years and older.

Authors:  Mingzhe Yang; Xuguang Zhang; Zhenkai Ding; Feijie Wang; Yufang Wang; Changya Jiao; Jie-Hua Chen
Journal:  BMC Public Health       Date:  2020-02-13       Impact factor: 3.295

5.  Isolated systolic hypertension and central blood pressure: Implications from the national nutrition and health survey in Taiwan.

Authors:  Shao-Yuan Chuang; Hsing-Yi Chang; Tsung-Ying Tsai; Hao-Min Cheng; Wen-Harn Pan; Chen-Huan Chen
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-22       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.